Home » Healthcare » Germany Periodontal Disease Market

Germany Periodontal Disease Market By Type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease, Type 4, Type 5); By Application (Non-surgical Treatment, Surgical Treatment, Application 3, Application 4, Application 5); By Therapeutics (Systematic Antibiotics, Local Antibiotics, Therapeutics 3, Therapeutics 4, Therapeutics 5); By End Users (Hospitals, Dental Clinics, Dental Academics, Research Institutes and Others, End Users 5); By Distribution Channel (Distribution Channel 1, Distribution Channel 2, Distribution Channel 3, Distribution Channel 4, Distribution Channel 5) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $2699

Published: | Report ID: 64175 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Germany Periodontal Disease Market Size 2023  USD 258.53 Million
Germany Periodontal Disease Market, CAGR  6.38%
Germany Periodontal Disease Market Size 2032  USD 459.59 Million

Market Overview

The Germany Periodontal Disease Market is projected to grow from USD 258.53 million in 2023 to USD 459.59 million by 2032, with a compound annual growth rate (CAGR) of 6.38%.

The Germany periodontal disease market is driven by the rising prevalence of periodontal conditions, heightened awareness of oral health, and advancements in dental treatment technologies. Increasing aging populations, along with the growing adoption of preventive dental care, further fuel market growth. The demand for minimally invasive treatments, such as laser therapy and regenerative techniques, is contributing to the shift toward more effective solutions. Additionally, the rise in health-consciousness and the integration of dental care into overall wellness regimes are leading to a surge in regular dental check-ups, boosting early detection and treatment. Technological innovations in diagnostics and treatment options, including AI-powered tools and advanced imaging systems, are enhancing the precision and efficiency of periodontal care. With these factors combined, the market is set for sustained expansion, as individuals seek more personalized and advanced solutions for managing periodontal diseases.

Germany’s periodontal disease market is influenced by regional factors such as population demographics, healthcare infrastructure, and local awareness of oral health. Key cities like Berlin and Munich are central hubs for periodontal care due to their advanced healthcare systems, large populations, and higher awareness of preventive dental care. The market benefits from Germany’s well-developed public health initiatives, which promote oral health and access to specialized treatments. Key players in the market include global and local companies such as Bausch Health Companies Inc., Henry Schein, Geistlich Pharma AG, and DENTSPLY SIRONA Inc., which provide a range of periodontal treatments, from non-surgical options to advanced regenerative procedures. These companies play a crucial role in driving innovation and expanding access to high-quality periodontal care across the country, addressing both preventive and advanced treatment needs for diverse patient populations.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Market Insights

  • The Germany periodontal disease market is valued at USD 258.53 million in 2023 and is expected to reach USD 459.59 million by 2032, growing at a CAGR of 6.38%.
  • The aging population in Germany is a significant driver, leading to an increased demand for periodontal treatments.
  • Rising awareness of the connection between oral health and overall well-being is contributing to market growth.
  • Healthcare costs and insurance reimbursement limitations remain a restraint, particularly for advanced treatments.
  • The shortage of specialized dental professionals, especially in rural areas, poses a challenge to widespread access to care.
  • Technological advancements in laser therapy and regenerative procedures are transforming treatment options.
  • Berlin and Munich are key regions with strong healthcare infrastructure and a high demand for specialized periodontal care.

Market Drivers

Rising Prevalence of Systemic Diseases

The increasing prevalence of systemic diseases, such as diabetes, cardiovascular diseases, and respiratory illnesses, is another key driver of the periodontal disease market in Germany. Research has shown that periodontal disease is closely linked to these conditions, with poor oral health exacerbating the severity of systemic diseases. For instance, a cross-sectional analysis published in Military Medical Research found significant associations between periodontal disease and various systemic conditions, including cardiovascular diseases and diabetes. As the incidence of these diseases rises, the number of individuals affected by periodontal issues also grows. This connection emphasizes the importance of addressing oral health as part of broader healthcare strategies, further fueling demand for periodontal care.

Lifestyle Factors

Unhealthy lifestyle habits, including smoking, excessive alcohol consumption, and poor oral hygiene, are major risk factors for periodontal disease. In Germany, these lifestyle factors, along with the pressures of modern living and busy schedules, contribute to the increasing prevalence of periodontal disease. For instance, a study published in the Journal of Sciences found that smoking and poor oral hygiene significantly increase the risk of periodontal disease. Smoking, in particular, is a well-established risk factor that compromises oral health, weakening the gums and increasing susceptibility to infection. As these habits remain prevalent in the population, the number of individuals seeking treatment for periodontal disease continues to rise.

Increased Awareness and Technological Advancements

There has been a noticeable increase in public awareness about the importance of oral health and the potential consequences of periodontal disease. As people become more informed, they are more likely to seek early detection and preventive measures. For instance, public health campaigns in Germany have successfully raised awareness about oral hygiene and the importance of regular dental check-ups. Additionally, advancements in dental technology, such as laser therapy, regenerative procedures, and minimally invasive treatments, have revolutionized the management of periodontal disease. These innovations not only enhance treatment outcomes but also provide patients with more effective and less invasive solutions.

Aging Population

Germany’s rapidly aging population plays a significant role in the growing demand for periodontal disease treatments. Older adults are more susceptible to periodontal conditions due to factors such as weakened immune systems, reduced salivary flow, and declining oral hygiene practices. As the proportion of elderly individuals in Germany continues to rise, the need for preventive measures and periodontal treatments increases. This demographic shift has led to higher demand for dental services focused on managing age-related oral health issues, including periodontal disease.

Market Trends

Demographic Shifts and Systemic Health Factors Driving Demand

Germany’s aging population is a primary driver for the growth of the periodontal disease market. As individuals age, they become more vulnerable to periodontal conditions due to weakened immune systems, reduced salivary flow, and other age-related factors that affect oral health. This demographic shift is increasing the demand for both preventive care and effective treatment options tailored to older adults. Furthermore, the rising prevalence of systemic diseases, such as diabetes, cardiovascular conditions, and respiratory illnesses, is exacerbating the incidence of periodontal disease. For instance, a cross-sectional analysis published in Military Medical Research found significant associations between periodontal disease and various systemic conditions, including cardiovascular diseases and diabetes. Research has shown that periodontal disease is closely linked to these systemic health issues, with poor oral health often worsening the severity of conditions like diabetes and heart disease. As the incidence of these diseases continues to rise, so does the need for specialized periodontal care. Together, these factors are fueling a heightened demand for periodontal treatments, especially as individuals seek more comprehensive solutions to address both their oral and overall health.

Technological Advancements, Awareness, and Healthcare Infrastructure

The growing awareness of the importance of oral health has led to earlier detection and more proactive treatment of periodontal disease. More people are undergoing regular dental check-ups and seeking preventive measures to avoid the progression of periodontal issues. This trend is also supported by advancements in dental technology, which have revolutionized the way periodontal disease is diagnosed and treated. Innovations like laser therapy, regenerative procedures, and other minimally invasive treatments offer effective solutions with quicker recovery times and fewer complications, making them increasingly popular among patients. Moreover, government initiatives and public health programs focused on raising awareness and improving access to dental care are playing a crucial role in market growth. These initiatives are enhancing public knowledge about the consequences of periodontal disease and making dental care more accessible to a broader population. Germany’s strong healthcare infrastructure, with its emphasis on preventive care and early diagnosis, further strengthens the market, providing individuals with the resources they need to address periodontal issues promptly. Together, these factors ensure continued growth in the periodontal disease market as both awareness and technology continue to improve.

Market Challenges Analysis

Challenges from Aging Population and Healthcare System Limitations

Germany’s aging population presents a significant challenge in the management of periodontal disease, as older adults often face multiple chronic health conditions that complicate treatment. The combination of periodontal disease with other conditions, such as diabetes and cardiovascular diseases, increases the complexity of care and raises the risk of adverse effects during treatment. For instance, a study by the European Federation of Periodontology highlights that the prevalence of periodontal disease remains high among the elderly, despite improvements in oral health over the past few decades. This complexity demands highly personalized treatment plans, which can be difficult to manage, especially as elderly patients may have multiple healthcare providers and medications. Additionally, although Germany has a public health insurance system that covers dental treatments, there are significant limitations when it comes to more advanced procedures. Co-payments and restricted coverage for specialized treatments can deter patients, particularly those in need of complex periodontal care, from seeking timely intervention. These financial barriers often lead to delayed treatment, worsening the overall prognosis of the disease and contributing to more severe health complications.

Shortage of Specialized Professionals and Patient Compliance Issues

The shortage of specialized dental professionals, particularly periodontists and dental hygienists, is another major challenge in addressing periodontal disease. This shortage is especially pronounced in rural areas, where access to specialized care is limited. As a result, many patients experience delays in diagnosis and suboptimal treatment, which can lead to the progression of periodontal disease to more advanced stages. Moreover, patient compliance remains a significant issue, as maintaining proper oral hygiene and following prescribed treatment plans can be difficult, especially for those with busy lifestyles. Poor compliance with oral health guidelines can undermine treatment outcomes, increasing the likelihood of disease recurrence. Despite the growing awareness of the importance of oral health, there is still a widespread underestimation of the impact of periodontal disease on overall health. Social stigma surrounding gum disease further discourages individuals from seeking the necessary care, hindering early detection and intervention. The lack of early detection and preventive measures means that many individuals do not prioritize regular dental check-ups, leading to the progression of the disease and the need for more invasive treatments. These combined challenges present significant obstacles to improving periodontal health in Germany.

Market Opportunities

Expansion of Preventive and Early Intervention Services

There is a significant market opportunity in Germany for expanding preventive and early intervention services for periodontal disease. As awareness of the link between oral health and overall well-being continues to rise, more individuals are seeking regular dental check-ups and preventive care. This growing demand presents opportunities for dental clinics and healthcare providers to offer specialized services focusing on early detection and personalized treatment plans. Additionally, with the aging population becoming more vulnerable to periodontal disease, there is a rising need for targeted preventive solutions aimed at older adults. By emphasizing the importance of routine oral health maintenance and providing tailored treatments for seniors, businesses can tap into a large and growing market segment.

Technological Innovations and Treatment Advancements

Technological advancements in periodontal disease treatment represent another lucrative opportunity for growth in Germany’s market. The development of minimally invasive treatments such as laser therapy, regenerative procedures, and AI-powered diagnostic tools is transforming the way periodontal conditions are managed. As these technologies improve in both efficacy and accessibility, there is a growing opportunity for providers to adopt these innovations and offer more efficient, effective, and comfortable treatments to patients. Additionally, the integration of digital health solutions and telemedicine platforms can enhance patient care by enabling remote consultations and monitoring, making periodontal care more convenient and accessible. Investing in these technological advancements can help businesses stay competitive while meeting the rising demand for innovative and non-invasive treatment options.

Market Segmentation Analysis:

By Type:

The Germany periodontal disease market is segmented into various types, including gingivitis, chronic periodontal disease, aggressive periodontal disease, and others. Gingivitis is the most common form of periodontal disease and primarily affects the gums, causing redness and swelling. As a less severe form, it can be treated with non-invasive methods such as cleaning and improved oral hygiene. Chronic periodontal disease, on the other hand, is more prevalent among adults and often results in the gradual loss of tooth-supporting structures. It typically requires a combination of non-surgical and surgical treatments. Aggressive periodontal disease is characterized by rapid destruction of the periodontal ligament and bone and can be seen in young adults, often linked to genetic factors. This segment represents a smaller but significant portion of the market. The “others” category includes rare or less common forms of periodontal conditions. Each type of periodontal disease requires different treatment approaches, creating opportunities for tailored solutions that address the unique needs of these segments.

By Application:

The market for periodontal disease treatments in Germany can also be analyzed based on application, primarily divided into non-surgical and surgical treatments. Non-surgical treatments, which include scaling and root planing, antibiotics, and laser therapy, represent a significant portion of the market due to their minimally invasive nature and effectiveness in treating mild to moderate periodontal conditions. Surgical treatments, including flap surgery, bone grafts, and soft tissue grafts, are required for advanced stages of periodontal disease where non-surgical methods are insufficient. These treatments have seen significant advancements, improving recovery times and outcomes. Other applications in the market, such as regenerative procedures and the use of advanced biomaterials, also contribute to the growth of the sector. With increasing demand for more effective, minimally invasive treatments, the market is seeing a shift toward the integration of technological innovations such as laser and regenerative therapies. This segmentation reflects the diverse approaches needed to manage periodontal disease and provides opportunities for both traditional and advanced treatment providers.

Segments:

Based on Type:

  • Gingivitis
  • Chronic Periodontal Disease
  • Aggressive Periodontal Disease
  • Type 4
  • Type 5

Based on Application:

  • Non-surgical Treatment
  • Surgical Treatment
  • Application 3
  • Application 4
  • Application 5

Based on Therapeutics:

  • Systematic Antibiotics
  • Local Antibiotics
  • Therapeutics 3
  • Therapeutics 4
  • Therapeutics 5

Based on End Users:

  • Hospitals
  • Dental Clinic
  • Dental Academics
  • Research Institutes and Others
  • End Users 5

Based on Distribution Channel:

  • Distribution Channel 1
  • Distribution Channel 2
  • Distribution Channel 3
  • Distribution Channel 4
  • Distribution Channel 5

Based on the Geography:

  • Berlin
  • Munich
  • Hamburg

Regional Analysis

Berlin

Berlin holds a significant share of the Germany periodontal disease market, accounting for approximately 30% of the overall market. As the capital and largest city in Germany, Berlin has a diverse population with a high concentration of healthcare providers, including dental clinics and specialized periodontists. The city’s demographic profile, with a growing elderly population, contributes to the increased demand for periodontal care. Berlin also benefits from its well-developed healthcare infrastructure, which includes state-of-the-art dental facilities and a strong emphasis on preventive care. The availability of advanced treatments, such as laser therapy and regenerative procedures, further supports market growth in the region. Additionally, the presence of public health initiatives focused on improving oral health awareness and access to care is driving the adoption of periodontal disease treatments. These factors combined make Berlin a crucial region in the market, with a significant opportunity for continued growth in periodontal care as demand for specialized treatments increases.

Munich

Munich, the capital of Bavaria, represents another key region in the German periodontal disease market, holding an estimated market share of around 25%. Known for its high standard of living and a large, health-conscious population, Munich has seen a growing demand for advanced dental treatments, particularly in the area of periodontal disease. The city is home to a wealth of private dental clinics and specialists offering both preventive and advanced treatment options. Munich’s residents are increasingly aware of the importance of oral health, leading to higher rates of regular dental check-ups and early intervention. Furthermore, the city benefits from a well-established healthcare system and access to cutting-edge dental technologies, including minimally invasive techniques and laser treatments. The market is also driven by an aging population, as older adults are more susceptible to periodontal disease and require specialized care. With these factors in play, Munich continues to be a strong player in the German periodontal disease market, demonstrating steady growth potential in both preventive and treatment sectors.

Key Player Analysis

  • Bausch Health Companies Inc
  • Henry Schein
  • Geistlich Pharma AG
  • Lyne Laboratories
  • ENVISTA HOLDINGS CORPORATION
  • DENTSPLY SIRONA Inc
  • 3M
  • Amyndas Pharmaceuticals
  • Biolase, Inc
  • Company 10
  • Company 11
  • Company 12
  • Company 13
  • Company 14

Competitive Analysis

The Germany periodontal disease market is highly competitive, with several key players leading the industry through innovative treatments and advanced technologies. Major players include Bausch Health Companies Inc., Henry Schein, Geistlich Pharma AG, Lyne Laboratories, ENVISTA Holdings Corporation, DENTSPLY Sirona Inc., 3M, Amyndas Pharmaceuticals, and Biolase, Inc. These companies are known for their diverse product portfolios that address a wide range of periodontal diseases, from gingivitis to advanced chronic conditions. Leading players differentiate themselves by offering a wide range of solutions to address various stages of periodontal disease, from early-stage gingivitis to severe chronic conditions. Companies are increasingly investing in research and development to improve treatment efficacy and reduce recovery times, particularly through minimally invasive options such as laser therapy and regenerative procedures. Technological advancements play a crucial role in enhancing diagnostic accuracy and treatment outcomes. The market also benefits from a growing demand for preventive care, with many companies offering tailored solutions to address the needs of different patient demographics, including the aging population. Despite the strong presence of established brands, smaller companies are also entering the market with niche products, particularly in regenerative medicine and specialized periodontal care. To stay competitive, firms are prioritizing customer education, ensuring patients understand the long-term benefits of early intervention and regular oral health maintenance. The focus on quality, patient experience, and technological innovation continues to shape the competitive landscape of the German periodontal disease market.

Recent Developments

  • In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
  • In June 2023, Eli Lilly and Company finalized an agreement to acquire DICE Therapeutics, Inc., a renowned biopharmaceutical firm recognized for its groundbreaking DELSCAPE technology platform. This platform is instrumental in creating novel oral therapeutic candidates, such as oral IL-17 inhibitors, which are presently in clinical development. These treatments are designed to target chronic immune-related diseases.
  • In March 2023, Haleon initiated the #BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
  • In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
  • In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
  • In February 2022, Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.

Market Concentration & Characteristics

The Germany periodontal disease market exhibits a moderate level of concentration, with a few dominant players holding significant market share, while also offering opportunities for smaller companies to introduce innovative solutions. The market is characterized by a combination of well-established global brands and emerging regional players, each contributing to the growth of the sector. Larger companies often focus on comprehensive product portfolios, offering everything from diagnostic tools to advanced treatment solutions, catering to both preventive and advanced care. These companies leverage their strong distribution networks, robust research and development capabilities, and extensive customer bases to maintain competitive advantages.

On the other hand, smaller players are carving out niche segments, particularly in areas such as regenerative medicine and laser-based treatments. These companies often focus on innovation, providing specialized solutions to address the evolving needs of patients and dental professionals. The market’s characteristics reflect an increasing demand for minimally invasive, effective, and patient-centric solutions. Technological advancements, including laser therapy, regenerative procedures, and digital diagnostic tools, are transforming treatment methodologies, leading to improved patient outcomes. Furthermore, growing public awareness about the importance of oral health and the rising prevalence of periodontal disease are fueling market growth, encouraging both established players and new entrants to expand their offerings.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Report Coverage

The research report offers an in-depth analysis based on Type, Application, Therapeutics, End Users, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The Germany periodontal disease market is expected to grow significantly, driven by an aging population and rising awareness of oral health.
  2. Increasing demand for preventive dental care and early-stage treatments will drive market growth.
  3. Advancements in minimally invasive treatment options, such as laser therapy, will continue to shape the market.
  4. Technological innovations in diagnostic tools and treatment procedures will improve outcomes and reduce recovery times.
  5. Growing focus on regenerative medicine and tissue engineering will lead to more effective treatments for severe periodontal conditions.
  6. The rising prevalence of systemic diseases like diabetes and cardiovascular diseases will contribute to an increased need for periodontal care.
  7. Public health initiatives and government programs aimed at promoting oral health will further fuel market expansion.
  8. The demand for specialized periodontal treatments will rise, leading to an increased focus on training and recruitment of dental professionals.
  9. As awareness increases, patients will seek more personalized and tailored periodontal treatment options.
  10. The market will see stronger collaboration between dental product manufacturers, healthcare providers, and researchers to enhance treatment strategies.

CHAPTER NO. 1 : INTRODUCTION 21
1.1.1. Report Description 21
Purpose of the Report 21
USP & Key Offerings 21
1.1.2. Key Benefits for Stakeholders 21
1.1.3. Target Audience 22
1.1.4. Report Scope 22
CHAPTER NO. 2 : EXECUTIVE SUMMARY 23
2.1. PERIODONTAL DISEASE Market Snapshot 23
2.1.1. Germany PERIODONTAL DISEASE Market, 2018 – 2032 (USD Million) 24
CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 25
3.1. Russia-Ukraine and Israel-Palestine War Impacts 25
CHAPTER NO. 4 : PERIODONTAL DISEASE MARKET – INDUSTRY ANALYSIS 26
4.1. Introduction 26
4.2. Market Drivers 27
4.2.1. Rising trend of cosmetic dentistry will be boosting the market in a positive way 27
4.2.2. Increasing number of clinics providing periodontal care will grow the market 28
4.3. Market Restraints 29
4.3.1. High treatment costs and limited access to advance treatment will impact the growth negatively 29
4.4. Market Opportunities 30
4.4.1. Market Opportunity Analysis 30
4.5. Porter’s Five Forces Analysis 31
4.6. Value Chain Analysis 32
4.7. Buying Criteria 33
CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 34
5.1. Import Analysis by Germany 34
5.1.1. Germany PERIODONTAL DISEASE Market Import Volume/Revenue, By Germany, 2018 – 2023 34
5.2. Export Analysis by Germany 35
5.2.1. Germany PERIODONTAL DISEASE Market Export Volume/Revenue, By Germany, 2018 – 2023 35
CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 36
6.1. Demand Analysis by Germany 36
6.1.1. Germany PERIODONTAL DISEASE Market Demand Volume/Revenue, By Germany, 2018 – 2023 36
6.2. Supply Analysis by Germany 37
6.2.1. Germany PERIODONTAL DISEASE Market Supply Volume/Revenue, By Germany, 2018 – 2023 37
CHAPTER NO. 7 : PRODUCTION ANALYSIS 38
7.1. Production Analysis by Germany 38
7.1.1. Germany PERIODONTAL DISEASE Market Production Volume/Revenue, By Germany, 2018 – 2023 38
CHAPTER NO. 8 : PRICE ANALYSIS 39
8.1. Price Analysis by Type 39
8.1.1. Germany PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 39
8.1.2. Germany Type Market Price, By Type, 2018 – 2023 39
CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 40
9.1. Key Raw Materials and Suppliers 40
9.2. Key Raw Materials Price Trend 40
CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 41
10.1. Manufacturing Cost Analysis 41
10.2. Manufacturing Process 41
CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 42
11.1. Company Market Share Analysis – 2023 42
11.1.1. Germany PERIODONTAL DISEASE Market: Company Market Share, by Volume, 2023 42
11.1.2. Germany PERIODONTAL DISEASE Market: Company Market Share, by Revenue, 2023 43
11.1.3. Germany PERIODONTAL DISEASE Market: Top 6 Company Market Share, by Revenue, 2023 43
11.1.4. Germany PERIODONTAL DISEASE Market: Top 3 Company Market Share, by Revenue, 2023 44
11.2. Germany PERIODONTAL DISEASE Market Company Volume Market Share, 2023 45
11.3. Germany PERIODONTAL DISEASE Market Company Revenue Market Share, 2023 46
11.4. Company Assessment Metrics, 2023 47
11.4.1. Stars 47
11.4.2. Emerging Leaders 47
11.4.3. Pervasive Players 47
11.4.4. Participants 47
11.5. Start-ups /SMEs Assessment Metrics, 2023 47
11.5.1. Progressive Companies 47
11.5.2. Responsive Companies 47
11.5.3. Dynamic Companies 47
11.5.4. Starting Blocks 47
11.6. Strategic Developments 48
11.6.1. Acquisitions & Mergers 48
New Product Launch 48
Germany Expansion 48
11.7. Key Players Product Matrix 49
CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 50
12.1. PESTEL 50
12.1.1. Political Factors 50
12.1.2. Economic Factors 50
12.1.3. Social Factors 50
12.1.4. Technological Factors 50
12.1.5. Environmental Factors 50
12.1.6. Legal Factors 50
12.2. Adjacent Market Analysis 50
CHAPTER NO. 13 : PERIODONTAL DISEASE MARKET – BY TYPE SEGMENT ANALYSIS 51
13.1. PERIODONTAL DISEASE Market Overview, by Type Segment 51
13.1.1. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 52
13.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Type 53
13.1.3. Incremental Revenue Growth Opportunity, by Type, 2024 – 2032 53
13.1.4. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 54
13.2. Gingivitis 55
13.3. Chronic Periodontal Disease 56
13.4. Aggressive Periodontal Disease 57
13.5. Type 4 58
13.6. Type 5 59
CHAPTER NO. 14 : PERIODONTAL DISEASE MARKET – BY APPLICATION SEGMENT ANALYSIS 60
14.1. PERIODONTAL DISEASE Market Overview, by Application Segment 60
14.1.1. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 61
14.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Application 62
14.1.3. Incremental Revenue Growth Opportunity, by Application, 2024 – 2032 62
14.1.4. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 63
14.2. Non-surgical Treatment 64
14.3. Surgical Treatment 65
14.4. Application 3 66
14.5. Application 4 67
14.6. Application 5 68
CHAPTER NO. 15 : PERIODONTAL DISEASE MARKET – BY THERAPEUTICS SEGMENT ANALYSIS 69
15.1. PERIODONTAL DISEASE Market Overview, by Therapeutics Segment 69
15.1.1. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 70
15.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Therapeutics 71
15.1.3. Incremental Revenue Growth Opportunity, by Therapeutics, 2024 – 2032 71
15.1.4. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 72
15.2. Systematic Antibiotics 73
15.3. Local Antibiotics 74
15.4. Therapeutics 3 75
15.5. Therapeutics 4 76
15.6. Therapeutics 5 77
CHAPTER NO. 16 : PERIODONTAL DISEASE MARKET – BY END USERS SEGMENT ANALYSIS 78
16.1. PERIODONTAL DISEASE Market Overview, by End Users Segment 78
16.1.1. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 79
16.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By End Users 80
16.1.3. Incremental Revenue Growth Opportunity, by End Users, 2024 – 2032 80
16.1.4. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 81
16.2. Hospitals 82
16.3. Dental Clinic 83
16.4. Dental Academics 84
16.5. Research Institutes and Others 85
16.6. End Users 5 86
CHAPTER NO. 17 : PERIODONTAL DISEASE MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS 87
17.1. PERIODONTAL DISEASE Market Overview, by Distribution Channel Segment 87
17.1.1. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 88
17.1.2. PERIODONTAL DISEASE Market Attractiveness Analysis, By Distribution Channel 89
17.1.3. Incremental Revenue Growth Opportunity, by Distribution Channel, 2024 – 2032 89
17.1.4. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 90
17.2. Distribution Channel 1 91
17.3. Distribution Channel 2 92
17.4. Distribution Channel 3 93
17.5. Distribution Channel 4 94
17.6. Distribution Channel 5 95
CHAPTER NO. 18 : PERIODONTAL DISEASE MARKET – GERMANY ANALYSIS 96
18.1. Type 96
18.1.1. Germany PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 96
18.2. Germany PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 96
18.3. Application 97
18.3.1. Germany PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 97
18.3.2. Germany PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 97
18.4. Therapeutics 98
18.4.1. Germany PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 98
18.4.2. Germany PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 98
18.5. End Users 99
18.5.1. Germany PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 99
18.5.2. Germany PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 99
18.6. Distribution Channel 100
18.6.1. Germany PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 100
18.6.2. Germany PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 100
CHAPTER NO. 19 : COMPANY PROFILES 101
19.1. Bausch Health Companies Inc 101
19.1.1. Company Overview 101
19.1.2. Product Portfolio 101
19.1.3. Swot Analysis 101
19.1.4. Business Strategy 102
19.1.5. Financial Overview 102
19.2. Henry Schein 103
19.3. Geistlich Pharma AG 103
19.4. Lyne Laboratories 103
19.5. ENVISTA HOLDINGS CORPORATION 103
19.6. DENTSPLY SIRONA Inc 103
19.7. 3M 103
19.8. Amyndas Pharmaceuticals 103
19.9. Biolase, Inc 103
19.10. Company 10 103
19.11. Company 11 103
19.12. Company 12 103
19.13. Company 13 103
19.14. Company 14 103

List of Figures
FIG NO. 1. Germany PERIODONTAL DISEASE Market Revenue, 2018 – 2032 (USD Million) 22
FIG NO. 2. Porter’s Five Forces Analysis for Germany PERIODONTAL DISEASE Market 29
FIG NO. 3. Value Chain Analysis for Germany PERIODONTAL DISEASE Market 30
FIG NO. 4. Germany PERIODONTAL DISEASE Market Import Volume/Revenue, By Germany, 2018 – 2023 32
FIG NO. 5. Germany PERIODONTAL DISEASE Market Export Volume/Revenue, By Germany, 2018 – 2023 33
FIG NO. 6. Germany PERIODONTAL DISEASE Market Demand Volume/Revenue, By Germany, 2018 – 2023 34
FIG NO. 7. Germany PERIODONTAL DISEASE Market Supply Volume/Revenue, By Germany, 2018 – 2023 35
FIG NO. 8. Germany PERIODONTAL DISEASE Market Production Volume/Revenue, By Germany, 2018 – 2023 36
FIG NO. 9. Germany PERIODONTAL DISEASE Market Price, By Type, 2018 – 2023 37
FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38
FIG NO. 11. Manufacturing Cost Analysis 39
FIG NO. 12. Manufacturing Process 39
FIG NO. 13. Company Share Analysis, 2023 40
FIG NO. 14. Company Share Analysis, 2023 41
FIG NO. 15. Company Share Analysis, 2023 41
FIG NO. 16. Company Share Analysis, 2023 42
FIG NO. 17. PERIODONTAL DISEASE Market – Company Volume Market Share, 2023 43
FIG NO. 18. PERIODONTAL DISEASE Market – Company Revenue Market Share, 2023 44
FIG NO. 19. PERIODONTAL DISEASE Market Revenue Share, By Type, 2023 & 2032 50
FIG NO. 20. Market Attractiveness Analysis, By Type 51
FIG NO. 21. Incremental Revenue Growth Opportunity by Type, 2024 – 2032 51
FIG NO. 22. PERIODONTAL DISEASE Market Revenue, By Type, 2018, 2023, 2027 & 2032 52
FIG NO. 23. Germany PERIODONTAL DISEASE Market for Gingivitis, Revenue (USD Million) 2018 – 2032 53
FIG NO. 24. Germany PERIODONTAL DISEASE Market for Chronic Periodontal Disease, Revenue (USD Million) 2018 – 2032 54
FIG NO. 25. Germany PERIODONTAL DISEASE Market for Aggressive Periodontal Disease, Revenue (USD Million) 2018 – 2032 55
FIG NO. 26. Germany PERIODONTAL DISEASE Market for Type 4, Revenue (USD Million) 2018 – 2032 56
FIG NO. 27. Germany PERIODONTAL DISEASE Market for Type 5, Revenue (USD Million) 2018 – 2032 57
FIG NO. 28. PERIODONTAL DISEASE Market Revenue Share, By Application, 2023 & 2032 59
FIG NO. 29. Market Attractiveness Analysis, By Application 60
FIG NO. 30. Incremental Revenue Growth Opportunity by Application, 2024 – 2032 60
FIG NO. 31. PERIODONTAL DISEASE Market Revenue, By Application, 2018, 2023, 2027 & 2032 61
FIG NO. 32. Germany PERIODONTAL DISEASE Market for Non-surgical Treatment, Revenue (USD Million) 2018 – 2032 62
FIG NO. 33. Germany PERIODONTAL DISEASE Market for Surgical Treatment, Revenue (USD Million) 2018 – 2032 63
FIG NO. 34. Germany PERIODONTAL DISEASE Market for Application 3, Revenue (USD Million) 2018 – 2032 64
FIG NO. 35. Germany PERIODONTAL DISEASE Market for Application 4, Revenue (USD Million) 2018 – 2032 65
FIG NO. 36. Germany PERIODONTAL DISEASE Market for Application 5, Revenue (USD Million) 2018 – 2032 66
FIG NO. 37. PERIODONTAL DISEASE Market Revenue Share, By Therapeutics, 2023 & 2032 68
FIG NO. 38. Market Attractiveness Analysis, By Therapeutics 69
FIG NO. 39. Incremental Revenue Growth Opportunity by Therapeutics, 2024 – 2032 69
FIG NO. 40. PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018, 2023, 2027 & 2032 70
FIG NO. 41. Germany PERIODONTAL DISEASE Market for Systematic Antibiotics, Revenue (USD Million) 2018 – 2032 71
FIG NO. 42. Germany PERIODONTAL DISEASE Market for Local Antibiotics, Revenue (USD Million) 2018 – 2032 72
FIG NO. 43. Germany PERIODONTAL DISEASE Market for Therapeutics 3, Revenue (USD Million) 2018 – 2032 73
FIG NO. 44. Germany PERIODONTAL DISEASE Market for Therapeutics 4, Revenue (USD Million) 2018 – 2032 74
FIG NO. 45. Germany PERIODONTAL DISEASE Market for Therapeutics 5, Revenue (USD Million) 2018 – 2032 75
FIG NO. 46. PERIODONTAL DISEASE Market Revenue Share, By End Users, 2023 & 2032 77
FIG NO. 47. Market Attractiveness Analysis, By End Users 78
FIG NO. 48. Incremental Revenue Growth Opportunity by End Users, 2024 – 2032 78
FIG NO. 49. PERIODONTAL DISEASE Market Revenue, By End Users, 2018, 2023, 2027 & 2032 79
FIG NO. 50. Germany PERIODONTAL DISEASE Market for Hospitals, Revenue (USD Million) 2018 – 2032 80
FIG NO. 51. Germany PERIODONTAL DISEASE Market for Dental Clinic, Revenue (USD Million) 2018 – 2032 81
FIG NO. 52. Germany PERIODONTAL DISEASE Market for Dental Academics, Revenue (USD Million) 2018 – 2032 82
FIG NO. 53. PERIODONTAL DISEASE Market Revenue Share, By Distribution Channel, 2023 & 2032 84
FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85
FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85
FIG NO. 56. PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86
FIG NO. 57. Germany PERIODONTAL DISEASE Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87
FIG NO. 58. Germany PERIODONTAL DISEASE Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88
FIG NO. 59. Germany PERIODONTAL DISEASE Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89
FIG NO. 60. Germany PERIODONTAL DISEASE Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90
FIG NO. 61. Germany PERIODONTAL DISEASE Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91
FIG NO. 62. Research Methodology – Detailed View 100
FIG NO. 63. Research Methodology 101

List of Tables
TABLE NO. 1. : Germany PERIODONTAL DISEASE Market: Snapshot 18
TABLE NO. 2. : Drivers for the PERIODONTAL DISEASE Market: Impact Analysis 22
TABLE NO. 3. : Restraints for the PERIODONTAL DISEASE Market: Impact Analysis 24
TABLE NO. 4. : Germany PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 34
TABLE NO. 5. : Key Raw Materials & Suppliers 35
TABLE NO. 6. : Germany PERIODONTAL DISEASE Market Revenue, By Type, 2018 – 2023 (USD Million) 89
TABLE NO. 7. : Germany PERIODONTAL DISEASE Market Revenue, By Type, 2024 – 2032 (USD Million) 89
TABLE NO. 8. : Germany PERIODONTAL DISEASE Market Revenue, By Application, 2018 – 2023 (USD Million) 90
TABLE NO. 9. : Germany PERIODONTAL DISEASE Market Revenue, By Application, 2024 – 2032 (USD Million) 90
TABLE NO. 10. : Germany PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2018 – 2023 (USD Million) 91
TABLE NO. 11. : Germany PERIODONTAL DISEASE Market Revenue, By Therapeutics, 2024 – 2032 (USD Million) 91
TABLE NO. 12. : Germany PERIODONTAL DISEASE Market Revenue, By End Users, 2018 – 2023 (USD Million) 92
TABLE NO. 13. : Germany PERIODONTAL DISEASE Market Revenue, By End Users, 2024 – 2032 (USD Million) 92
TABLE NO. 14. : Germany PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2018 – 2023 (USD Million) 93
TABLE NO. 15. : Germany PERIODONTAL DISEASE Market Revenue, By Distribution Channel, 2024 – 2032 (USD Million) 93

Frequently Asked Questions:

What is the current size of the Germany Periodontal Disease market?

The Germany periodontal disease market is valued at USD 258.53 million in 2023 and is projected to grow to USD 459.59 million by 2032, with a compound annual growth rate (CAGR) of 6.38%.

What factors are driving the growth of the Germany Periodontal Disease market?

The market is driven by an aging population, increasing awareness of the connection between oral and overall health, technological advancements in treatment methods like laser therapy, and the rising prevalence of systemic diseases such as diabetes and cardiovascular conditions. Growing adoption of preventive dental care and regular check-ups also contribute significantly to market growth.

What are the key segments within the Germany Periodontal Disease market?

The market is segmented by type (Gingivitis, Chronic Periodontal Disease, Aggressive Periodontal Disease), application (Non-surgical and Surgical Treatments), therapeutics (Systematic and Local Antibiotics), and geography (Berlin, Munich, Hamburg, and other regions). Non-surgical treatments dominate due to their minimally invasive nature and popularity among patients.

What are some challenges faced by the Germany Periodontal Disease market?

Challenges include limited access to specialized dental professionals, particularly in rural areas, healthcare costs and reimbursement limitations for advanced treatments, and patient compliance issues related to maintaining proper oral hygiene. Additionally, the aging population poses complexities in treatment due to comorbidities.

Who are the major players in the Germany Periodontal Disease market?

Key players include Bausch Health Companies Inc., Henry Schein, Geistlich Pharma AG, Lyne Laboratories, ENVISTA Holdings Corporation, DENTSPLY Sirona Inc., 3M, Amyndas Pharmaceuticals, and Biolase, Inc. These companies focus on innovative solutions such as regenerative procedures, laser therapies, and advanced diagnostics to meet the growing demand for periodontal treatments.

Germany Elevator Modernization Market

Published:
Report ID: 69962

Germany Luxury Interior Design Market

Published:
Report ID: 69908

Germany Industrial Design Market

Published:
Report ID: 69356

Germany Peripheral Vascular Devices Market

Published:
Report ID: 69349

Germany Safety Gloves Market

Published:
Report ID: 69170

Germany K-Beauty Product Market

Published:
Report ID: 69167

Germany Polyether Modified Polysiloxane (PMP) Market

Published:
Report ID: 68096

Germany Digital Radiography Market

Published:
Report ID: 68093

Spinal Osteosynthesis Units Market

Published:
Report ID: 70023

Musculoskeletal Oncology Therapeutics Market

Published:
Report ID: 70005

Marburg Virus Disease Therapeutics Market

Published:
Report ID: 69979

Inhaled Nitric Oxide Delivery Systems Market

Published:
Report ID: 69953

Infant Care And Baby Care Equipment Market

Published:
Report ID: 69944

High Potency API Contract Manufacturing Market

Published:
Report ID: 69923

Frontotemporal Dementia Management Market

Published:
Report ID: 69888

Fragmentable Nasal and Ear Dressing Market

Published:
Report ID: 69869

Fertility And Pregnancy Rapid Tests Market

Published:
Report ID: 69848

Pharmacy and Drug Store Franchises Market

Published:
Report ID: 69799

Pharmaceutical Cleaning Validation Market

Published:
Report ID: 69793

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing.
$2699

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis and multi-location access, making it an excellent choice for organizations with distributed workforce.
$3699

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc.’s research team. It is highly recommended for organizations seeking to execute short, customized research projects related to the scope of the purchased report.
$5699

Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN